Titlebook: Stem Cell Mobilization; Methods and Protocol Mikhail G. Kolonin,Paul J. Simmons Book 2012 Springer Science+Business Media, LLC 2012 bone ma

机构

Hematopoietic Progenitor Cell Apheresis Processing, patients who have mobilized with myeloid growth factors, CXCR4 antagonists or upon recovery from cytotoxic chemotherapy. The duration of apheresis during the days in which elevated numbers of CD34 positive cells are present in the blood depends upon the efficiency of the apheresis maneuver, the num

convert

Toxicities of Mobilized Stem Cell Infusion,e toxicities can be related to volume of infusion, dimethylsulfoxide (DMSO) or bacterial or viral infection of the infused cell products. Serious toxicities including hypotension and hypertension, cardiac arrhythmias, and respiratory failure require the prompt attention by a trained physician. Non-l

警告

Mobilization of Hematopoietic Stem Cells by Depleting Bone Marrow Macrophages,cellular components of HSC niches, particularly osteoblasts and their progenitors, and to inhibit the production of HSC supportive cytokines and chemokines. Although the mechanisms by which niche cells are inhibited by mobilizing treatments is still incompletely understood, it has recently emerged t

BLAZE

袋鼠

Vascular Progenitor Cell Mobilization, underlying neovascularization will translate into innovative clinical treatment strategies for a wide variety of disease processes. Vascular precursor/progenitor cell populations have been isolated from several different tissue types and have a rich potential for use in vascular regenerative strate

FOIL

Evaluation of Circulating Endothelial Precursor Cells in Cancer Patients,he clinic, EPCs are present in the peripheral blood of cancer patients in higher numbers than in healthy subjects. These cells are mobilized from the bone marrow compartment to the periphery in response to certain cytokines and growth factors. Growing body of evidence suggests that following acute c

occurrence

crescendo

突袭

扫兴